Liver transplantation for patients with hepatobiliary malignancies other than hepatocellular carcinoma
Beavers KL, Bonis PA, Lau J
Record ID 32002000432
This technology assessment reviews the available evidence regarding the outcomes of liver transplantation in patients with primary and metastatic liver tumours other than hepatocellular carcinoma (HCC), and patients with preexisting, non-hepatic malignancies.
Authors' recomendations: Liver transplantation for tumours other than HCC is performed uncommonly in the United States, reflecting the infrequent occurence of some of these tumours as well as the recognition that survival in such patients is poor compared to patients transplanted for nonmalignant causes. Nevertheless, the long-term survivors continue to be described suggesting that transplantation may be beneficial in individual cases. The available evidence does not provide a clear profile of patients who might be optimal candidates for such therapy.
Authors' methods: Systematic review
Project Status: Completed
URL for project: http://www.ahrq.gov/
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
- Liver Transplantation
- Biliary Tract Neoplasms
- Liver Neoplasms
Organisation Name: Agency for Healthcare Research and Quality
Contact Address: Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name: email@example.com
Contact Email: firstname.lastname@example.org
Copyright: Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.